Skip to main content
Equibles

D. E. Shaw & Co., Inc.

Position in RDY — Dr Reddys Laboratories Ltd

CIK 1009207 New York, NY
Back to RDY Full portfolio

Position in RDY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,833,347
-$85,584 QoQ
Shares Held
126,525
-8.7% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 238 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $657,589,731 across 42 Drug Manufacturers - Specialty & Generic names. RDY ranks #30 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LQDA
Liquidia Corp
 1,267,706 $101,074,198
2 ALKS
Alkermes plc.
 1,312,031 $68,750,423
3 XERS
Xeris Biopharma Holdings, Inc.
 7,804,758 $61,813,683
4 PCRX
Pacira BioSciences, Inc.
 1,950,332 $49,479,922
5 ZTS
Zoetis Inc.
 537,515 $38,625,827
6 KNSA
Kiniksa Pharmaceuticals International, plc
 569,756 $36,435,896
7 SUPN
Supernus Pharmaceuticals, Inc.
 767,668 $35,704,237
8 TAK
Takeda Pharmaceutical Co Ltd
 2,049,467 $32,852,956

All Filings in RDY

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,833,347 126,525
2026-03-31 $1,918,931 138,551
2025-12-31 $584,400 41,624
2025-03-31 $240,189 18,210
2024-12-31 $6,787,915 429,887
2024-09-30 $9,585,483 120,648
2023-12-31 $706,793 10,158
2023-06-30 $1,755,530 27,817
2023-03-31 $7,867,839 138,202
2022-12-31 $3,765,226 72,758
2022-09-30 $4,667,000 89,167
2022-06-30 $13,571,823 245,023
2022-03-31 $16,873,316 302,769
2021-12-31 $9,698,144 148,267
2021-09-30 $5,767,821 88,545
2021-06-30 $11,406,987 155,176
2021-03-31 $7,854,789 127,949
2020-12-31 $10,378,612 145,583
2020-09-30 $9,877,589 142,001
2020-06-30 $8,307,568 156,717
2020-03-31 $10,585,374 262,469